Heartflow (NASDAQ:HTFL) CEO John C.M. Farquhar Sells 32,676 Shares of Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 32,676 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $45.00, for a total value of $1,470,420.00. Following the transaction, the chief executive officer owned 388,044 shares of the company’s stock, valued at $17,461,980. This represents a 7.77% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Friday, August 14th, John C.M. Farquhar sold 15,560 shares of Heartflow stock. The stock was sold at an average price of $39.06, for a total value of $607,773.60.
• On Monday, August 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total value of $638,730.22.
• On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $27.75, for a total transaction of $626,095.50.
• On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The stock was sold at an average price of $35.00, for a total transaction of $1,361,500.00.
• On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total transaction of $643,017.00.

Heartflow Stock Up 2.8%

HTFL stock opened at $46.80 on Friday. Heartflow, Inc. has a 52 week low of $20.13 and a 52 week high of $47.95. The company has a fifty day simple moving average of $30.33 and a two-hundred day simple moving average of $28.17. The firm has a market capitalization of $4.07 billion and a P/E ratio of -25.57.

Heartflow (NASDAQ:HTFL) last posted its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The firm had revenue of $64.08 million for the quarter. The business’s revenue was up 47.7% on a year-over-year basis. As a group, analysts anticipate that Heartflow, Inc. will post -0.82 EPS for the current year.

Institutional Trading of Heartflow

Several institutional investors have recently added to or reduced their stakes in the company. XXEC Inc. bought a new position in shares of Heartflow during the second quarter valued at approximately $2,524,764,000. BlackRock Inc. bought a new stake in shares of Heartflow during the 2nd quarter worth approximately $152,502,000. Wellington Management Group LLP purchased a new position in Heartflow during the 3rd quarter valued at $164,263,000. Bamco Inc. NY purchased a new position in Heartflow during the 2nd quarter valued at $94,625,000. Finally, Jupiter Topco LLC bought a new position in Heartflow in the 2nd quarter valued at $70,983,000.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on HTFL shares. Robert W. Baird set a $45.00 price objective on Heartflow in a research report on Friday, August 14th. Benchmark reissued a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. William Blair started coverage on Heartflow in a report on Monday, May 4th. They set an “outperform” rating on the stock. Freedom Capital upgraded Heartflow to a “strong-buy” rating in a research report on Tuesday, June 30th. Finally, Canaccord Genuity Group lifted their price objective on shares of Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a research note on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $43.43.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.